Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/117353) titled 'Skin Sensitization Potential of UAE Retinol plus Peptide Serum' on Sept. 9.
Study Type: Interventional
Study Design:
Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Open Label
Primary Sponsor: Mosaic Wellness Pvt Ltd
Intervention:
Intervention1: Finn Chamber: Each Patch contain 0.04gm,(40 microliter) of test sample 1. UAE Retinol + Peptide Serum Administration: Topical, Frequency: every second day- as per ISO 10993 Part 10, Duration: 41 days
Control Intervention1: Not Applicable: Not Applicable
Recruitm...